Cerecin

Share Interview Share Compensation

N/A

Clinical Trials (1)

NCT00660088Safety of Three Formulations of Ketasyn Administered for 14 Days in Healthy Elderly

N/A

Help build intelligence for Cerecin

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Deep pipeline focus on Alzheimer's disease with multiple programs across Phase 1-3, including Tricaprilin in Phase 3 trials representing a lead asset with clinical momentum.
Specialized expertise in an underexplored modality (medium-chain triglycerides as medical foods) offers differentiated career positioning in a high-unmet-need neurology segment.
Neurology therapeutic area provides exposure to one of pharma's largest disease burdens with significant clinical and commercial upside.

Watch Out For

Zero active job postings and absent hiring data suggest the company may be in a contraction phase, scaling back or consolidating operations.
Lack of financial, employee, and founding date transparency raises concerns about company stability, runway, and growth prospects for career security.

Generated by Claude from Cerecin's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Caprylic Triglyceride

Relapsing Remitting MS

N/A

Clinical Trials (1)

NCT01848327Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis

N/A

Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With A

N/A

Clinical Trials (1)

NCT01538212Retrospective Cohort Study Of The Efficacy Of Axona® (Medium Chain Triglycerides) In Patients With Alzheimer's Disease

N/A

AC-1204 mixed in water

Phase 1

Clinical Trials (1)

NCT02959710Evaluation of PK of AC-1204 Mixed in Water, AC-1202 Mixed in Water, and AC-1202 Mixed in Ensure® on Ketone Body Production

Phase 1

Tricaprilin

Phase 1

Clinical Trials (1)

NCT03971123Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production

Phase 1

AC-1202

Phase 1

Clinical Trials (1)

NCT05028114Tricaprilin Liquid Formulation PK Study

Phase 1

Caprylic Triglyceride Oil

Phase 1

Clinical Trials (1)

NCT02833012Evaluation of PK of Caprylic Triglyceride Oil, AC-1202, AC-1204, and Axona on Ketone Body Production

Phase 1

AC-OLE-01-VA

Taste Profile Assessments

Phase 1

Clinical Trials (1)

NCT05408780A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects

Phase 1

Tricaprilin

Phase 1

Clinical Trials (1)

NCT03628352Taste-masking Study for Tricaprilin in Sensory Panelists

Phase 1

Tricaprilin

Infantile Spasm

Phase 1

Clinical Trials (1)

NCT04727970Tricaprilin Infantile Spasms Pilot Study

Phase 1

AC-1204

Phase 1

Clinical Trials (1)

NCT02747602Evaluation of PK of AC1204 v Caprylic Triglyceride Oil Incl Food Effect on Ketone Body Production

Phase 1

Tricaprilin

Phase 1

Clinical Trials (1)

NCT04268953Study to Compare the Pharmacokinetics of Daily Administration of Tricaprilin on Ketone Body Production

Phase 1

AC-1202

Phase 1

Clinical Trials (1)

NCT03063645Study to Compare the Pharmacokinetics of AC 1202 and Two Doses of AC-SD-01 on Ketone Body Production

Phase 1

AC-OLE-01-VA

Phase 1

Clinical Trials (1)

NCT05628636AC-OLE-01-VA Tolerability Study in Healthy Participants Under Different Dosing Conditions

Phase 1

tricaprilin

Phase 1

Clinical Trials (1)

NCT03551769Pharmacokinetics of Tricaprilin Including Food Effect on Ketone Body Production

Phase 1

MCTprocal medical food

Age-Associated Memory Impairment

Phase 1

Clinical Trials (1)

NCT03635879Medical Food Formulation Pharmacokinetic (PK) Study in Medium Chain Triglycerides

Phase 1

Tricaprilin

Phase 2

Clinical Trials (1)

NCT00355550Tricaprilin In Age-Associated Memory Impairment

Phase 2

Tricaprilin

Phase 2

Clinical Trials (1)

NCT00142805Tricaprilin in Mild to Moderate Alzheimer's Disease

Phase 2

Tricaprilin

Migraine

Phase 2

Clinical Trials (1)

NCT04437199Tricaprilin Phase 2 Pilot Study in Migraine

Phase 2

caprylic triglyceride

Phase 2/3

Clinical Trials (1)

NCT01211782AC-1204 Long-term Efficacy Response Trial (ALERT Protocol)

Phase 2/3

AC-1204

Phase 2/3

Clinical Trials (1)

NCT01741194AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext

Phase 2/3

Tricaprilin

Phase 3

Clinical Trials (1)

NCT05809908Tricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) Study

Phase 3

Tricaprilin